Sign inJoin waitlistJoin the waitlist

Fatima Karzai

Branch Clinical Director · Clinical Center at the National Institutes of Health

Credentials: · · ·

History

Clinical Center at the National Institutes of Health
Present

National Cancer Institute
Internal Medicine
George Washington University Medical School

Research

Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
Journal for ImmunoTherapy of Cancer · 2019 · 238 citations
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
Journal for ImmunoTherapy of Cancer · 2018 · First of 27 authors · 233 citations
A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening
Clinical Cancer Research · 2018 · 180 citations

Ravi Madan
55 papers
James Gulley
47 papers
WD
William Dahut
38 papers
Marijo Bilusic
23 papers
William Figg
19 papers
Ismail Turkbey
14 papers
Peter Choyke
13 papers
Charalampos Floudas
11 papers · 2 as a fellow
Peter Pinto
11 papers
Julius Strauss
10 papers
David VanderWeele
9 papers
Jason Redman
9 papers · 1 as a fellow

Clinical trials

Precision-Based Genomics in Prostate Cancer
Principal investigator · Recruiting
National Cancer Institute (NCI)
2021–2030
BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
Principal investigator · Terminated · Phase 1
National Cancer Institute (NCI)
2021
Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2019–2027
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2019–2026